common-pharma-interest common-risks-of-working-as-a-healthcare-professional 
Intouch Solutions
MARCH 13, 2024
As a creative professional entrenched in the health and wellness industry, I naturally pondered “How could this translate to the pharma marketing world?” From Viewers to Engaged Brand Community With Culture-Driven Content : This session began with rooting us in the reality that online ads aren’t working the way they used to.
pharmaphorum
JANUARY 24, 2023
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 25, 2021
Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events. Before COVID, pharma events were mainly face-to-face. The changing events model.
XTalks
JANUARY 5, 2021
There will also be more focus on digitization of research and development and manufacturing spaces to increase efficiencies and interconnectivity in the pharma, biotech and medical device industries. This year will see the rolling out of much-awaited pandemic-ending COVID-19 vaccines. 1. COVID-19 Pandemic: An Evolving Era.
pharmaphorum
JANUARY 27, 2023
Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.
XTalks
AUGUST 18, 2020
SalivaDirect, a saliva-based COVID-19 test that was tested among players of the National Basketball Association (NBA), has been given emergency use authorization (EUA) by the US Food and Drug Administration (FDA). The EUA comes after Yale partnered with the NBA to study the efficacy of the saliva-based test. Cheap and Accessible.
Pharma Marketing Network
JUNE 8, 2020
Don (PMN): Hi good morning everyone, welcome to the pharma marketing podcast. I come to the pharma space from being a medical operator of clinics for the last 15 to 20 years where we took care of patients with specific disease conditions that were often overlooked. Bob and Mark thanks for joining us today. Mark (83Bar): Yea thank you.
Expert insights. Personalized for you.
105 
Let's personalize your content